J. Turner

发表

Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide

B. Lebleu, M. Gait, A. Arzumanov, 2007, Nucleic acids research.

Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.

Simon W. Jones, M. Lindsay, B. Sproat, 2007, Bioconjugate chemistry.

RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.

Simon W. Jones, M. Gait, A. Arzumanov, 2007, Blood cells, molecules & diseases.

Peptide Conjugates of Oligonucleotide Analogs and siRNA for Gene Expression Modulation

A. Arzumanov, G. Ivanova, J. Turner, 2006 .

Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide.

G. Sczakiel, A. Detzer, M. Overhoff, 2009, RNA.

Methods for L-ribooligonucleotide sequence determination using LCMS

S. Klußmann, S. Vonhoff, J. Turner, 2011, Nucleic acids research.

MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity.

Simon W. Jones, M. Lindsay, M. Gait, 2007, Molecular bioSystems.

Anti‐HIV Activity of Steric Block Oligonucleotides

A. Lever, J. Toulmé, S. Reigadas, 2006, Annals of the New York Academy of Sciences.

Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide

B. Lebleu, M. Gait, A. Arzumanov, 2007, Nucleic acids research.

Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.

B. Lebleu, S. Resina, P. Prévot, 2007, International journal of pharmaceutics.

Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide

B. Lebleu, M. Gait, A. Arzumanov, 2007, Nucleic acids research.

Disulfide Conjugation of Peptides to Oligonucleotides and Their Analogs

M. Gait, D. Owen, J. Turner, 2006, Current protocols in nucleic acid chemistry.

Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents.

T. Zatsepin, M. Gait, J. Turner, 2005, Current pharmaceutical design.

Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides

M. Gait, A. Arzumanov, J. Turner, 2005, Nucleic acids research.

Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells

B. Lebleu, B. Verbeure, M. Gait, 2005, Nucleic acids research.

Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: chemistry and cell delivery.

M. Gait, A. Arzumanov, G. Ivanova, 2006, Biochimica et biophysica acta.

RNA targeting in cells by peptide conjugates of peptide nucleic acids (PNA)

B. Lebleu, M. Gait, R. Abes, 2008 .

Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides.

P. Iversen, H. Moulton, B. Lebleu, 2007, Biochemical Society transactions.